Trial Profile
The Efficacy and Safety of Re-Challenge Platinum plus Pemetrexed Combination Therapy for Recurrent Malignant Pleural Mesothelioma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Platinum complexes (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 19 Oct 2015 New trial record
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.